| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $41,907,108 ) (Continued on the next page) |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA266592 | The Role of IL-15 in Cutaneous T-cell Lymphoma Progression | 000 | 4 | NIH | 6/30/2026 | $356,850 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR082460 | The role of endogenous low molecular weight mineralization inhibitors in spine health | 001 | 3 | NIH | 5/14/2026 | $34,193 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR082460 | The role of endogenous low molecular weight mineralization inhibitors in spine health | 000 | 3 | NIH | 12/11/2025 | $615,468 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | T2554964 | Addiction Medicine Fellowship | 00 | 2 | HRSA | 5/27/2026 | $600,000 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DE033025 | Investigating a new vulnerability in oral squamous cell carcinoma | 000 | 4 | NIH | 5/12/2026 | $521,948 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01ES033197 | METTL3 in chromium-induced angiogenesis and carcinogenesis | 000 | 5 | NIH | 1/22/2026 | $519,475 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA267549 | WNT pathway-driven anti-estrogen therapy resistance in breast cancer | 000 | 4 | NIH | 5/5/2026 | $564,048 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HG012784 | Specialized Tools and Auto-updatable Scalable Interactive Databases to Study isomiRs, tRFs and rRFs in Human and Mouse | 000 | 4 | NIH | 6/25/2026 | $542,847 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM147191 | From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors | 000 | 5 | NIH | 4/24/2026 | $390,000 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI155666 | miR-21 regulation of autoreactive B cell and lupus nephritis development | 000 | 5 | NIH | 7/1/2026 | $533,851 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA263506 | MiR-152/PKM2/SLC7A5 axis in breast cancer development, chemo- and radiation-treatment response | 000 | 5 | NIH | 3/30/2026 | $644,810 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA262570 | Pharmacological Jak2 inhibition to overcome androgen receptor aberrations in prostate cancer | 000 | 5 | NIH | 3/30/2026 | $591,355 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21NS145175 | Early Detection of Respiratory Impairments in ALS: A Novel Diagnostic Approach | 000 | 1 | NIH | 6/8/2026 | $196,250 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL175371 | Role of tRNA- and rRNA-derived RNAs in acute lung injury | 000 | 3 | NIH | 6/16/2026 | $614,417 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA268899 | A novel strategy for transcriptional reprogramming of lymphoid leukemia cells | 001 | 5 | NIH | 4/16/2026 | $54,001 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA268899 | A novel strategy for transcriptional reprogramming of lymphoid leukemia cells | 000 | 5 | NIH | 12/18/2025 | $486,021 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI156384 | Role of IL-7R in CNS autoimmunity | 000 | 5 | NIH | 1/22/2026 | $390,000 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | T32GM144302 | Training Grant in Cellular, Biochemical and Molecular Sciences | 000 | 5 | NIH | 5/25/2026 | $323,493 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL173113 | Allosteric modulation of beta2- adrenoceptors in the treatment of asthma | 000 | 3 | NIH | 4/27/2026 | $555,192 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA258849 | Provider Support and Patient Outreach in Lung Cancer Screening | 000 | 5 | NIH | 6/26/2026 | $654,854 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | T32HD117733 | Clinical Pharmacology Training Program | 001 | 2 | NIH | 4/27/2026 | $204,979 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI160189 | IL-37: a novel regulator of inflammation in CNS autoimmunity | 000 | 5 | NIH | 2/10/2026 | $390,000 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM138109 | Elucidating the Mechanism in the Regulation of RNA-binding Protein Phase Separation | 000 | 6 | NIH | 5/13/2026 | $429,000 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01GM159406 | Mechanisms of Lytic Granules Exocytosis | 000 | 1 | NIH | 2/18/2026 | $567,411 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R03AI202317 | Mitochondrial solute carriers on phagosomes in dendritic cells | 000 | 1 | NIH | 7/7/2026 | $78,500 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL179441 | Role of isoAsp-induced protein damage in diabetic angiogenesis | 000 | 1 | NIH | 7/7/2026 | $629,068 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21MH138289 | DNA-PK impact on HIV reservoir in the CNS | 000 | 1 | NIH | 5/18/2026 | $431,750 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | P01CA298993 | Neuroendocrine Prostate Cancer Progression and Novel Therapeutic Vulnerabilities | 000 | 1 | NIH | 4/27/2026 | $1,656,379 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F31CA309862 | Bi-functional degrader with treatment potential for B-cell lymphoma | 000 | 1 | NIH | 5/13/2026 | $50,114 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21DA065026 | Xylazine, Pregnancy, and Access to Care | 001 | 1 | NIH | 4/7/2026 | $0 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21DA065026 | Xylazine, Pregnancy, and Access to Care | 000 | 1 | NIH | 2/12/2026 | $346,500 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AI194176 | Avian influenza virus prevention in the domestic host by a deactivated vaccine | 000 | 1 | NIH | 6/19/2026 | $221,250 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA301616 | Spatial heterogeneity of Her2 expression in luminal breast cancer | 000 | 1 | NIH | 5/1/2026 | $646,208 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DA066166 | A novel mechanism that regulates CNS viral load and reservoir upon substance use | 000 | 1 | NIH | 5/14/2026 | $723,388 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL178828 | GRK5 regulation of GPCR signaling in platelets. | 000 | 1 | NIH | 5/4/2026 | $763,379 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS079702 | Respiratory interneuron circuit plasticity: promoting recovery of diaphragm function after spinal cord injury | 000 | 14 | NIH | 5/22/2026 | $542,250 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AI190614 | The Role of the GPR15-C10ORF99 Pathway in T cell Homing during Eosinophilic Esophagitis | 000 | 2 | NIH | 1/22/2026 | $195,000 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK138011 | Relevance of fatty acid handling in the adaptive response to mitochondrial dysfunction | 000 | 3 | NIH | 2/26/2026 | $523,115 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS115862 | Factors contributing to unawareness of performance errors after left hemisphere stroke | 002 | 6 | NIH | 3/3/2026 | $612,423 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM156496 | Biogenesis and function of cyclic phosphate-containing RNAs | 001 | 2 | NIH | 3/11/2026 | $42,900 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM156496 | Biogenesis and function of cyclic phosphate-containing RNAs | 000 | 2 | NIH | 1/21/2026 | $386,100 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AI191986 | Function of HIV-1 Env cytoplasmic tail domain | 001 | 3 | NIH | 1/26/2026 | $195,000 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS134987 | Neuroimaging and Connectome Analysis as a Diagnostic and Prognostic Biomarker of SCI Induced Neuropathic Pain | 001 | 3 | NIH | 2/28/2026 | $56,450 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS134987 | Neuroimaging and Connectome Analysis as a Diagnostic and Prognostic Biomarker of SCI Induced Neuropathic Pain | 000 | 3 | NIH | 12/16/2025 | $508,059 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | UG1CA233341 | Sidney Kimmel Cancer Center LAPS Institutional Collaboration | 001 | 6 | NIH | 6/18/2026 | $0 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | UG1CA233341 | Sidney Kimmel Cancer Center LAPS Institutional Collaboration | 000 | 6 | NIH | 5/25/2026 | $544,790 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA269750 | Multi-modality detection of RCC Recurrence Post Ablation | 002 | 4 | NIH | 4/16/2026 | $58,325 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA269750 | Multi-modality detection of RCC Recurrence Post Ablation | 001 | 4 | NIH | 2/13/2026 | $524,929 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA284017 | Deciphering the role of NELFE in modulating MYC signaling in HCC | 000 | 4 | NIH | 6/3/2026 | $356,850 |
|
